| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 17,700 | 18,400 | 12:33 | |
| 17,700 | 18,400 | 12:28 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.08.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 12.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.08.2024ISIN NameCA0079756007 AETERNA... ► Artikel lesen | |
| 12.08. | XFRA Z61: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILARCEDE PHARMA AB... ► Artikel lesen | |
| 06.08. | Spotlight Stock Market: Market Notice 165/24 - Arcede Pharma AB will be delisted after close of the market on August 9, 2024 | ||
| 27.06. | Spotlight Stock Market: Market notice 137/24 - Arcede Pharma ABs share, ARCEDE, is moved to the Observation List |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.11. | COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs | Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE... ► Artikel lesen | |
| 12.11. | COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer | ||
| 08.10. | Cosciens Biopharma Inc: Cosciens Biopharma director Egbert resigns | ||
| 08.10. | COSCIENS Biopharma strukturiert Vorstand um | ||
| 08.10. | COSCIENS Biopharma reshuffles board of directors |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.11. | Monopar Therapeutics GAAP EPS of -$0.37 | ||
| 08.11. | Monopar Therapeutics Inc.: Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments | In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid... ► Artikel lesen | |
| 08.11. | Monopar Therapeutics - 8-K, Current Report | ||
| 08.11. | Monopar Therapeutics - 10-Q, Quarterly Report | ||
| 30.10. | Finanzvorstand von Monopar Therapeutics erwirbt Stammaktien im Wert von 25.187 US-Dollar |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.11. | Park Lawn Corp: Park Lawn Further Expands in Texas Through Acquisition of Callaway Jones | TORONTO, ON / ACCESSWIRE / November 4, 2024 / Park Lawn Corporation ("Park Lawn" or "PLC") is pleased to announce that, today, it acquired substantially all the assets of Callaway-Jones Funeral Home... ► Artikel lesen | |
| 10.09. | Park Lawn Corp: Park Lawn Continues Growth Strategy by Expanding Presence in North Carolina and Central Texas and Announces Leadership Changes | TORONTO, ON / ACCESSWIRE / September 10, 2024 / Park Lawn Corporation ("Park Lawn" or "PLC") is pleased to announce that, on August 5, 2024, it acquired substantially all the assets of Carolina Memorial... ► Artikel lesen | |
| 12.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.08.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 12.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.08.2024ISIN NameCA0079756007 AETERNA... ► Artikel lesen | |
| 10.08. | Park Lawn Corp: Park Lawn to be delisted from TSX Aug. 12 | ||
| 09.08. | Park Lawn Corp: Park Lawn completes going-private deal |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.08. | Pro DV: Nach der schlimmen Nachricht | Im Juli ist Uwe Osterkamp, Vorstandssprecher von Pro DV gestorben. Dies hat eine große Lücke in der Gesellschaft hinterlassen. Ein weiterer Todesfall sowie mehrere Krankheitsfälle im Unternehmen sind... ► Artikel lesen | |
| 27.08. | PRO DV: Erstes Halbjahr von Schicksalsschlägen geprägt | Laut SMC-Research sei der Geschäftsfortgang bei der PRO DV AG im ersten Halbjahr durch überraschende Schicksalsschläge behindert worden. Nach Einschätzung des SMC-Analysten Adam Jakubowski habe man... ► Artikel lesen | |
| 13.08. | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.08.2024 | Das Instrument PDA0 DE000A4096T1 PRO DV AG INH O.N. KONV. EQUITY hat seinen ersten Handelstag am 13.08.2024: CONTINUOUS TRADING WITH AUCTIONS, PAG GER0, SettlCurr EUR, CCP Y
The instrument PDA0 DE000A4096T1... ► Artikel lesen | |
| 13.08. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 13.08.2024 | The following instruments on XETRA do have their first trading 13.08.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 13.08.2024
Aktien
1 US36321W1053 Galderma Group AG ADR
2... ► Artikel lesen | |
| 12.08. | XETR DELETION OF INSTRUMENTS FROM XETRA - 12.08.2024 | The following instruments on XETRA do have their last trading day on 12.08.2024Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 12.08.2024.ISIN Name DE0006967805 PRO DV AG ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.08.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 12.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.08.2024ISIN NameCA0079756007 AETERNA... ► Artikel lesen | |
| 02.08. | OTC Markets Group Welcomes TC Bancshares, Inc. to OTCQX | NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced TC Bancshares... ► Artikel lesen | |
| 01.08. | TC Bancshares, Inc. - 15-12G, Securities registration termination | ||
| 22.07. | TC Bancshares, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| 12.07. | TC Bancshares, Inc. - 8-K, Current Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.11. | Chutes & Ladders-Trevena teeters on edge with C-suite shakedown | ||
| 07.11. | Trevena teeters in dangerous territory, terminating CEO and other execs amid strategic review | ||
| 07.11. | Trevena GAAP EPS of -$5.79 | ||
| 07.11. | Trevena Inc.: Trevena Reports Third Quarter 2024 Results and Provides Business Update | CHESTERBROOK, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with... ► Artikel lesen | |
| 07.11. | TREVENA INC - 10-Q, Quarterly Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.09. | Green light given to Vintage Wine Estates asset sales | ||
| 02.09. | New bids made for Vintage Wine Estates assets | ||
| 27.08. | Bids mount for Vintage Wine Estates assets | ||
| 21.08. | Vintage Wine Estates 'gets green light to sell brands to Foley Family Wines' | ||
| 20.08. | Vintage Wine Estates Wins Approval to Sell Brands to Foley Firm |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ARCEDE PHARMA AB | 0,000 | 0,00 % |
| COSCIENS BIOPHARMA INC | 2,780 | 0,00 % |
| MONOPAR THERAPEUTICS INC | 19,600 | +7,69 % |
| PARK LAWN CORPORATION | 17,400 | 0,00 % |
| PRO DV AG | 2,400 | 0,00 % |
| TC BANCSHARES INC | 11,700 | 0,00 % |
| TREVENA INC | 0,153 | 0,00 % |
| VINTAGE WINE ESTATES INC | 0,010 | 0,00 % |
